As a non-profit organization, ACRES is led by its Executive Office and Board of Directors. These individuals are internationally-recognized and respected individuals who are champions for innovation and integration in clinical research.
The ACRES Alliance is a consortium of like-minded organizations and stakeholders that share the ACRES vision and bring their expertise to the ACRES initiatives.
Co-Founder & President / Chief Executive Officer, ACRES
Senior Scientist, James Mongan Institute for Health Policy
Associate Professor of Anesthesia, Massachusetts General Hospital, Harvard Medical School, Boston, MA
CEO, Syndax Pharmaceuticals
Managing Director, MPM Capital
Associate Professor of Clinical Medicine, Columbia University; former Senior Vice President, Worldwide Policy at Pfizer; former Senior Vice President for External Policy at Merck; former Assistant Secretary for Health, US Department of Health and Human Services
Founder and President, Clinical Data Interchange Standards Consortium (CDISC)
Former Chief Medical Officer of ICON; Chairperson, Fighting Blindness; Director, European Collaborative Centre for Clinical Trials in Rare Diseases and Irish Medicines Board; EMA Scientific Advisory Committee on Diabetes and Metabolism
CEO, EXOCHAIN, CORP; Chief Technology Officer, ACRES;
Recently, COO and Board Member, Sonavation; Formerly, CTO, EMC Global Security Group; CTO, Verified Person; Co-founder & CTO, CyberMedica; CTO, CMGI Incubator; CTO, Motorola, Internet and Networking Group
Head, Global Development Operations, Novartis; Previously, CEO and co-founder of Remarque Systems (technology); SVP and Global Head, Data and Safety Monitoring, Quintiles; VP of Enterprise Analytics and Business Process Management, Quintiles Innovation
Principal, Willow Pointe Consulting Group. Former VP, Business Communications and Stakeholder Engagement and VP, Government Advocacy at ASTELLAS; Director, State Government Affairs at NOVARTIS. Medical Marketing and Media (MM&M) Hall of Femme Award 2017.
Veeva Systems, Chief Strategy Officer; Previously, Chief Commercial Officer, PPD, Inc;
Accenture LLP, Global Managing Director, Accenture Life Sciences R&D
Dean, Duke-National University of Singapore Graduate School of Medicine Professor and Chair, Department of Psychiatry, Duke University School of Medicine
Senior Scientist, James Mongan Institute for Health Policy Associate Professor of Anesthesia, Massachusetts General Hospital Harvard Medical School, Boston, MA
Principal, IMPACT LLC, Gambrills, MD; Co-Founder, Chesapeake IRB
Founder and Managing Director, IMPACT LLC, Gambrills, MD; Formerly: Outside Lead Consultant, OPM; University of Maryland, College Park University Honors Program
Formerly, Financial Director, C. R. Smith Museum, American Airlines
CEO, EXOCHAIN, CORP;
Formerly COO and Board Member, Sonavation.
Chair of the Site Accreditation and Standards Initiative (SASI); CEO Quality Management Institute
Principal Consultant, NDA Regulatory Science Ltd, Surrey, UK Director of International; Society of Pharmacovigilance Secretariat Ltd, UK
President and Founder, TrialSiteNews LLC
Widler & Schiemann Ltd, Quality Risk Management & Quality by Design Former Global Head Quality, Hoffmann-La Roche Ltd., Basel, Switzerland
Sr Scientific Advisor /Professor, Clinical Pharmacology, Semmelweis University, Budapest, Hungary
General Director, Hungarian National Institute of Pharmacy;
Serves on Executive Board of the IMI-PharmaTrain.
Formerly: Internal Counsel, Genzyme
Widler & Schiemann Ltd, Quality Risk Management & Quality by Design Former Global Head Quality, Hoffmann-La Roche Ltd., Basel, Switzerland
Executive Vice President, Research Dataware, LLC, (a WIRB-Copernicus Group Company), Cambridge, MA